NOTES RECEIVABLE |
6 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||
| Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||
| NOTES RECEIVABLE | NOTE 3. NOTES RECEIVABLE
Notes receivable were as follows at June 30, 2026 and December 31, 2025:
Notes receivable consist of a promissory note received from Nobility LLC as partial consideration in connection with the sale of Nobility Healthcare on January 8, 2026, recorded at an estimated fair value of $1,117,303 at origination using an effective interest rate of 8% per annum. During the six months ended June 30, 2026, the carrying value reflected $52,874 of discount amortization and accrued interest and provisional earn-out adjustments of $439,053, of which $81,134 was recognized in the second quarter, resulting in a net carrying value of $731,124 at June 30, 2026. The earn-out adjustments are recognized within loss from discontinued operations. Cumulative provisional principal reductions of $429,886 reduced the face amount of the note from $1,140,499 to $710,613, and remain subject to revision upon receipt of the formal measurement statements. See Note 22, Discontinued Operations.
|
||||||||||||||||||||||||||||||||||||